Literature DB >> 20414103

Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases.

W Glenn McCluggage1, Daniel P Hurrell, Kathryn Kennedy.   

Abstract

Metastatic tumors within the cervix are uncommon if one excludes endometrial carcinoma, which involves the cervix by direct spread. A variety of other neoplasms rarely metastasize to the cervix and, in most cases, the diagnosis is straightforward because of a combination of clinical and pathologic parameters, common features of metastatic carcinoma within the cervix including predominant involvement of the deep stroma, absence of surface involvement and of an in situ component, and prominent lymphovascular permeation. We describe 6 cases of metastatic adenocarcinoma involving the cervix with superficial "mucosal" involvement mimicking primary cervical adenocarcinoma or adenocarcinoma in situ. In 5 cases, the primary adenocarcinoma was in the ovary or peritoneum and was of serous (4 cases) or clear-cell (1 case) type. In the other case, the primary neoplasm was in the pancreas and this was initially interpreted as a primary cervical adenocarcinoma. In the cases of primary ovarian or peritoneal carcinoma, the mucosal tumor within the cervix, which was discovered at the same time as the ovarian or peritoneal neoplasm, raised the possibility of synchronous independent lesions or metastasis from the cervix to the ovary or peritoneum. Positive staining for WT1, p53, and estrogen receptor in the cases of serous carcinoma and an absence of human papillomavirus by linear array genotyping in all cases was of value in excluding a primary cervical neoplasm, although these ancillary studies are supplementary to microscopic examination. In those cases with an ovarian or peritoneal primary, the likely pathogenesis of the cervical involvement is transtubal and intrauterine spread. It is important for the pathologist to be aware of the possibility of cervical mucosal metastasis to avoid an erroneous diagnosis of a primary cervical adenocarcinoma or adenocarcinoma in situ.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414103     DOI: 10.1097/PAS.0b013e3181d6b8fd

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  Secondary malignancies of the uterine cervix: a potential diagnostic pitfall.

Authors:  Gian Franco Zannoni; Valerio Gaetano Vellone; Marco Petrillo; Guido Fadda; Esther Diana Rossi; Giovanni Scambia; Arnaldo Carbone
Journal:  Virchows Arch       Date:  2013-06-10       Impact factor: 4.064

2.  The clinical significance of occult gynecologic primary tumours in metastatic cancer.

Authors:  M B Hannouf; E Winquist; S M Mahmud; M Brackstone; S Sarma; G Rodrigues; P K Rogan; J S Hoch; G S Zaric
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

3.  International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.

Authors:  Simona Stolnicu; Iulia Barsan; Lien Hoang; Prusha Patel; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Malcolm C Pike; Esther Oliva; Kay J Park; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2018-02       Impact factor: 6.394

4.  International Endocervical Adenocarcinoma Criteria and Classification: Validation and Interobserver Reproducibility.

Authors:  Anjelica Hodgson; Kay J Park; Bojana Djordjevic; Brooke E Howitt; Marisa R Nucci; Esther Oliva; Simona Stolnicu; Bin Xu; Robert A Soslow; Carlos Parra-Herran
Journal:  Am J Surg Pathol       Date:  2019-01       Impact factor: 6.394

5.  Molecular Characterization of an Endometrial Endometrioid Adenocarcinoma Metastatic to a Thyroid Hürthle Cell Adenoma Showing Cancerization of Follicles.

Authors:  Amir H Afrogheh; Emily Meserve; Peter M Sadow; Antonia E Stephen; Vânia Nosé; Suzanne Berlin; William C Faquin
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

6.  Cervical carcinomas with serous-like papillary and micropapillary components: illustrating the heterogeneity of primary cervical carcinomas.

Authors:  Richard Wing-Cheuk Wong; Joshua Hoi Yan Ng; Kam Chu Han; Yuen Ping Leung; Chiu Man Shek; Kin Nam Cheung; Carmen Ka Man Choi; Ka Yu Tse; Philip P C Ip
Journal:  Mod Pathol       Date:  2020-07-22       Impact factor: 7.842

7.  Direct sampling of metastatic ovarian carcinoma masquerading as endocervical adenocarcinoma in liquid-based cytology cervical sample.

Authors:  Nalini Gupta; Vikrant Bhar; Pranab Dey; Arvind Rajwanshi; Vanita Suri
Journal:  J Cytol       Date:  2014-07       Impact factor: 1.000

8.  Ovarian Carcinoma Presenting With a Large Cervical Mass.

Authors:  Melek Tugce Yilmaz; Ezgi Gurlek; Melis Gultekin; Korhan Kahraman; Mehmet C Salman; Alp Usubutun; Deniz Akata; Eser Lay Ergun; Zafer Arik; Ferah Yildiz
Journal:  Cureus       Date:  2022-01-06

9.  Secondary Involvement of the Uterine Cervix by Nongynecologic Neoplasms: A Detailed Clinicopathologic Analysis.

Authors:  Gulisa Turashvili; Wesley R Samore; Esther Oliva; Olga Ioffe; Robert Riddell; Kay J Park; Lars-Christian Horn
Journal:  Am J Surg Pathol       Date:  2020-12       Impact factor: 6.298

10.  Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report.

Authors:  Masafumi Toyoshima; Yuta Momono; Hiromitsu Makino; Takako Kudo; Naomi Oka; Junko Sakurada; Hiroyoshi Suzuki; Hideaki Kodama; Kosuke Yoshinaga
Journal:  World J Surg Oncol       Date:  2016-01-25       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.